34702 related articles for article (PubMed ID: 19081451)
1. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
3. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
4. Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients.
Bralet MC; Falissard B; Neveu X; Lucas-Ross M; Eskenazi AM; Keefe RS
Eur Psychiatry; 2007 Sep; 22(6):365-70. PubMed ID: 17434715
[TBL] [Abstract][Full Text] [Related]
5. Brief assessment of cognition in schizophrenia: validation of the Japanese version.
Kaneda Y; Sumiyoshi T; Keefe R; Ishimoto Y; Numata S; Ohmori T
Psychiatry Clin Neurosci; 2007 Dec; 61(6):602-9. PubMed ID: 18081619
[TBL] [Abstract][Full Text] [Related]
6. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
7. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
[TBL] [Abstract][Full Text] [Related]
8. [French version of TASTE (test for the ability and evaluation)].
Masson AM; Cadot M; Pereira AM; Depreeuw E; Ansseau M
Encephale; 2001; 27(6):527-38. PubMed ID: 11865560
[TBL] [Abstract][Full Text] [Related]
9. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
11. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
Stip E; Caron J; Renaud S; Pampoulova T; Lecomte Y
Compr Psychiatry; 2003; 44(4):331-40. PubMed ID: 12923712
[TBL] [Abstract][Full Text] [Related]
12. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between insight and self-reported quality of life among shizophrenic patients].
Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
[TBL] [Abstract][Full Text] [Related]
15. [Learning potential and cognitive remediation in schizophrenia].
Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
[TBL] [Abstract][Full Text] [Related]
16. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dimensions in first-episode schizophrenia spectrum disorders.
González-Blanch C; Crespo-Facorro B; Alvarez-Jiménez M; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Barquero JL
J Psychiatr Res; 2007 Dec; 41(11):968-77. PubMed ID: 17049561
[TBL] [Abstract][Full Text] [Related]
18. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
Favrod J; Ernst F; Giuliani F; Bonsack C
Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment of executive function as a core symptom of schizophrenia.
Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
